Venturi Wealth Management LLC Has $29,000 Stock Holdings in Teleflex Incorporated (NYSE:TFX)

Venturi Wealth Management LLC reduced its holdings in shares of Teleflex Incorporated (NYSE:TFX) by 52.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 161 shares of the medical technology company’s stock after selling 175 shares during the quarter. Venturi Wealth Management LLC’s holdings in Teleflex were worth $29,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Vontobel Holding Ltd. raised its position in Teleflex by 21.9% in the 4th quarter. Vontobel Holding Ltd. now owns 1,393 shares of the medical technology company’s stock valued at $248,000 after buying an additional 250 shares during the last quarter. Simplify Asset Management Inc. bought a new stake in shares of Teleflex in the 3rd quarter worth $4,800,000. JPMorgan Chase & Co. lifted its position in shares of Teleflex by 14.3% during the third quarter. JPMorgan Chase & Co. now owns 155,158 shares of the medical technology company’s stock valued at $38,374,000 after purchasing an additional 19,466 shares in the last quarter. Sumitomo Mitsui Trust Group Inc. boosted its holdings in Teleflex by 5.2% during the fourth quarter. Sumitomo Mitsui Trust Group Inc. now owns 108,231 shares of the medical technology company’s stock worth $19,263,000 after purchasing an additional 5,322 shares during the last quarter. Finally, Lecap Asset Management Ltd. bought a new stake in Teleflex in the 4th quarter worth about $729,000. 95.62% of the stock is owned by institutional investors.

Teleflex Stock Down 0.1 %

TFX stock opened at $177.45 on Thursday. Teleflex Incorporated has a fifty-two week low of $165.62 and a fifty-two week high of $249.90. The stock has a fifty day moving average of $177.07 and a 200-day moving average of $206.17. The company has a market capitalization of $8.24 billion, a price-to-earnings ratio of 35.28, a PEG ratio of 1.73 and a beta of 1.16. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42.

Analyst Upgrades and Downgrades

A number of analysts recently commented on the company. Truist Financial decreased their price target on Teleflex from $227.00 to $200.00 and set a “hold” rating for the company in a research report on Wednesday, December 18th. StockNews.com raised Teleflex from a “hold” rating to a “buy” rating in a research report on Thursday, November 28th. Mizuho cut their price target on shares of Teleflex from $275.00 to $250.00 and set a “neutral” rating on the stock in a report on Friday, November 1st. Royal Bank of Canada reduced their price target on shares of Teleflex from $275.00 to $245.00 and set an “outperform” rating for the company in a research report on Friday, November 1st. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of Teleflex in a research report on Monday, December 16th. Three investment analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $246.00.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.